US equities |
INTC $119.13 ▼-0.17% MU $1,074.89 ▲+0.00% NVDA $233.95 ▲+0.00% SNDK $1,719.99 ▲+0.00% SPCX $158.96 ▲+0.00% AMD $633.91 ▲+0.00% WDC $415.29 ▲+0.00% TSLA $370.59 ▲+0.00%
FinancialContent

Articles published by Valion Bio, Inc.

News headline image
Valion Bio and Shear Kershman Laboratories Successfully Formulate Oral Mucosal Entolimod; Valion Sees Potential for Multi-Fold Expansion of Long-Term Opportunity
From Valion Bio, Inc.
Via ACCESS Newswire
Tickers VBIO
News headline image
Valion Appoints Life Sciences Veteran Dean Zikria as Interim CEO and Announces Board Leadership Transitions
From Valion Bio, Inc.
Via ACCESS Newswire
Tickers VBIO
News headline image
Valion Bio Regains Compliance with NASDAQ Minimum Bid Price Listing Rule
From Valion Bio, Inc.
Via ACCESS Newswire
Tickers VBIO
News headline image
Valion Bio Announces Changes to Management and Board of Directors
From Valion Bio, Inc.
Via ACCESS Newswire
Tickers VBIO
News headline image
Valion Bio Announces Reverse Stock Split
From Valion Bio, Inc.
Via ACCESS Newswire
Tickers VBIO
News headline image
Ukraine's Ministry Of Health Advances Entolimod Review Into Technical Assessment Phase
From Valion Bio, Inc.
Via ACCESS Newswire
Tickers VBIO
News headline image
Valion Bio Announces U.S. Government-Funded Entolimod Studies Targeting Lethal Radiation-Induced GI Injury
From Valion Bio, Inc.
Via ACCESS Newswire
Tickers VBIO